InterCare DX, Inc. (ICCO)
- Previous Close
0.0884 - Open
0.0185 - Bid --
- Ask --
- Day's Range
0.0884 - 0.0884 - 52 Week Range
0.0171 - 0.0884 - Volume
3,200 - Avg. Volume
770 - Market Cap (intraday)
6.701M - Beta (5Y Monthly) 0.08
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0090 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
InterCare DX, Inc. operates as a biomedical and other software products development and services company. It creates, publishes, and markets software products that are embedded with sound, text, and video for relaxation training and stress management. The company also develops an integrated Internet-ready and RFID enabled applications, which target education, hospitality, legal system, human capital, and healthcare industry markets. Its products comprise e-Learning Integrated Technology Enterprise Systems for integrated tuition, boarding and lodging management, enterprise vendor portal, customer relationship management, enterprise budgeting, and financial management, as well as other tools used in administering education at all levels; InterCare Clinical Explorer, a software application designed to integrate virtually all aspects of the healthcare enterprise; and InterCare Vascular Diagnostic Center to measure vascular health in patients before exhibiting symptoms. The company was formerly known as InterCare Diagnostics. InterCare DX, Inc. was founded in 1991 and is based in Hawthorne, California. InterCare DX, Inc.is a subsidiary of Meridian Holdings, Inc.
www.intercare.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: ICCO
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ICCO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ICCO
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-296,512.28%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-811.26k
Diluted EPS (ttm)
-0.0090
Balance Sheet and Cash Flow
Total Cash (mrq)
223
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-504.45k